Bio Vantage
High quality stock analysis on biotech and pharmaceutical companies
Tuesday, July 31, 2012
Amarin's AM101 received FDA approval on July 26, 2012
Amarin's AM101 received FDA approval on July 26 for treatment
for patients with very high triglycerides.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment